As a result, we feel that in order to better serve MonoGen shareholders, creditors, employees and other stakeholders we must seek to identify additional alternatives for the support of our continued new product development efforts as well as the commercial activities associated with the MonoPrep System, perhaps through a sale of the company or its assets.